share_log

Pineapple Financial And 1 Other Stock Under $1 Insiders Are Buying

Pineapple Financial And 1 Other Stock Under $1 Insiders Are Buying

菠萝金融和另外1只股票低于1美元,内部人正在购买
Benzinga ·  08/05 09:13

The Dow Jones index closed lower by over 600 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道琼斯指数周五下跌超过600点。当内部人士购买或出售股票时,这表明他们对公司前景的信心或担忧。对于有兴趣投资或交易低价股票的投资者和交易者,可以将此视为其整体投资或交易决策的因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是几个近期关于低价股的值得关注的内部交易。了解更多,请查看Benzinga内幕交易平台。

Pineapple Financial

菠萝融资

  • The Trade: Pineapple Financial Inc. (NYSE:PAPL) CSO Christa Lillian Mitchell bought a total of 2,000 shares at an average price of $1.02. To acquire these shares, it cost around $2,040.
  • What's Happening: On July 16, Pineapple Financial posted a wider-than-expected quarterly loss.
  • What Pineapple Financial Does: Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers.
  • 交易:Pineapple Financial Inc.(纽交所:PAPL)首席战略官Christa Lillian Mitchell以平均价1.02美元购买了总共2,000股。要取得这些股票,花费了约2,040美元。
  • 最新消息:7月16日,Pineapple Financial公布了一季度的亏损超出预期。
  • Pineapple Financial Inc是一家加拿大抵押贷款科技和券商公司,为加拿大抵押贷款经纪人、券商、子券商、券商和消费者提供抵押贷款经纪服务和技术解决方案。

Vivos

Vivos

  • The Trade: Vivos Inc. (OTC:RDGL) President and CEO Michael K Korenko acquired a total of 50,000 shares at an average price of $0.09. To acquire these shares, it cost around $4,360.
  • What's Happening: On June 28, Vivos submitted the application to the FDA for authority to initiate human clinical trials.
  • What Vivos Does: Vivos Inc is a radiation oncology medical device company
  • 交易:Vivos Inc.(场外交易:RDGL)总裁兼首席执行官Michael k Korenko以平均价0.09美元购买了总共50,000股。要取得这些股票,花费了约4,360美元。
  • 正在发生什么事:6月28日,Vivos提交了向FDA申请,以获得启动人类临床试验的授权。
  • Vivos Inc.是一家放射治疗医疗器械公司。
  • Wall Street's Most Accurate Analysts' Views On 3 Materials Stocks Delivering High-Dividend Yields
  • 华尔街最准确的分析师对3只提供高股息收益的材料股的观点
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发